Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review
With a Little Help From My Friends : the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease. / Nyvad, Jakob; Lerman, Amir; Lerman, Lilach O.
In: Hypertension (Dallas, Tex. : 1979), Vol. 79, No. 4, 04.2022, p. 717-725.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review
}
TY - JOUR
T1 - With a Little Help From My Friends
T2 - the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease
AU - Nyvad, Jakob
AU - Lerman, Amir
AU - Lerman, Lilach O
PY - 2022/4
Y1 - 2022/4
N2 - The collateral circulation can adapt to bypass major arteries with limited flow and serves a crucial protective role in coronary, cerebral, and peripheral arterial disease. Emerging evidence indicates that the renal collateral circulation can similarly adapt and thereby limit kidney ischemia in atherosclerotic renovascular disease. These adaptations predominantly include recruitment of preexisting microvessels for arteriogenesis, with de novo vessel formation playing a limited role. Yet, adaptations of the renal collateral circulation in renovascular disease are often insufficient to fully compensate for the limited flow within an obstructed renal artery and may be hampered by the severity of obstruction or patient comorbidities. Experimental strategies have attempted to circumvent limitations of collateral formation and improve the prognosis of patients with various ischemic vascular territories. These have included pharmacological approaches such as endothelial growth factors, renin-angiotensin-aldosterone system blockade, and If-channel-blockers, as well as interventions like preconditioning, exercise, enhanced external counter-pulsation, and low-energy shock-wave therapy. However, few of these strategies have been implemented in atherosclerotic renovascular disease. This review summarizes current understanding regarding the development of renal collateral circulation in atherosclerotic renovascular disease. Studies are needed to apply lessons learned in other vascular beds in the setting of atherosclerotic renovascular disease to develop new treatment regimens for this patient group.
AB - The collateral circulation can adapt to bypass major arteries with limited flow and serves a crucial protective role in coronary, cerebral, and peripheral arterial disease. Emerging evidence indicates that the renal collateral circulation can similarly adapt and thereby limit kidney ischemia in atherosclerotic renovascular disease. These adaptations predominantly include recruitment of preexisting microvessels for arteriogenesis, with de novo vessel formation playing a limited role. Yet, adaptations of the renal collateral circulation in renovascular disease are often insufficient to fully compensate for the limited flow within an obstructed renal artery and may be hampered by the severity of obstruction or patient comorbidities. Experimental strategies have attempted to circumvent limitations of collateral formation and improve the prognosis of patients with various ischemic vascular territories. These have included pharmacological approaches such as endothelial growth factors, renin-angiotensin-aldosterone system blockade, and If-channel-blockers, as well as interventions like preconditioning, exercise, enhanced external counter-pulsation, and low-energy shock-wave therapy. However, few of these strategies have been implemented in atherosclerotic renovascular disease. This review summarizes current understanding regarding the development of renal collateral circulation in atherosclerotic renovascular disease. Studies are needed to apply lessons learned in other vascular beds in the setting of atherosclerotic renovascular disease to develop new treatment regimens for this patient group.
KW - atherosclerosis
KW - collateral circulation
KW - kidney
KW - prognosis
KW - renal artery
U2 - 10.1161/HYPERTENSIONAHA.121.17960
DO - 10.1161/HYPERTENSIONAHA.121.17960
M3 - Review
C2 - 35135307
VL - 79
SP - 717
EP - 725
JO - Hypertension
JF - Hypertension
SN - 0194-911X
IS - 4
ER -